HLA-DRA and non-small cell lung carcinoma: As to their prognostic values, seven genes could not predict the clinical outcome in NSCLC and lung squamous cell carcinoma (LUSC), while CD2 and HLA-DRA were associated with the improved prognosis in lung adenocarcinoma (LUAD) (Figs. 2C-E).